US Patent Issued to ARO Biotherapeutics on March 31 for "CD71 binding fibronectin type III domains" (Pennsylvania Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,589,159, issued on March 31, was assigned to ARO Biotherapeutics Co. (Philadelphia).

"CD71 binding fibronectin type III domains" was invented by Russell C. Addis (Philadelphia), Zhanna Druzina (Philadelphia), Robert Kolakowski (Philadelphia), Swapnil Kulkarni (Philadelphia), Steven G. Nadler (Philadelphia), Karyn O'Neil (Philadelphia) and Yao Xin (Philadelphia).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to polypeptides, such as fibronectin type III (FN3) domains that can bind CD71, their conjugates, isolated nucleotides encoding the molecules, vectors, host-cells, as well as methods of making and using the same."

The ...